Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132030) titled 'Analysis of the Application of Artificial Intelligence Technology in the Prospects of Primary Diabetic Retinopathy Screening' on Sept. 9.
Study Type: Diagnostic test
Study Design:
Diagnostic test for accuracy
Primary Sponsor: First Hospital of Nanping
Condition:
Diabetic retinopathy
Intervention:
Gold Standard:Optical Coherence Tomography Angiography (OCTA) or Fundus Fluorescein Angiography (FFA) is used as the gold standard to diagnose whether someone has diabetic retinopathy and whether it requires intervention.
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-10-01
Ta...